On Demand 2023 Practice Management Course

You can earn up to 4.25 AMA PRA Category 1 Credit(s)TM.

Price: $45 College members, $60 non-members

This one-day program is designed for office administrators and physician practice leaders alike and delivers dynamic updates on efficiently and effectively running your allergy practice. The PMP covers key allergy practice management topics, and our presenters are all experts in their field. 

Program Outline

2023 Allergy Coding Update / Leading for Change
Financial Performance Monitoring / Revenue Cycle Management
Crucial Conversations / ACAAI Practice Management Resources
Remote Patient Monitoring / Emergency Preparedness

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 4.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

  • Office practice administrators/managers
  • Nurse managers and other clinical staff responsible for practice management activities
  • New and established allergist-immunologists in private practice
  • Fellows in training

Learning Objectives

Upon completion of this session, participants should be able to:

  • Cite coding changes and requirements that impact your documentation and revenue cycle.
  • Employ the essential elements of change leadership such as engagement, empowerment and collaboration.
  • Demonstrate how the use of metrics and analysis can lead to effective performance monitoring.
  • Employ best practices to maximize the efficiency and profitability of your revenue cycle.
  • Develop skills to work through disagreements and achieve better results.
  • Access helpful College practice management resources.
  • Identify devices appropriate for RPM.
  • Create logistics for implementing RPM in practice.
  • Develop effective disaster planning protocols.
Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Attendance
  • 5.00 CBRN
Course opens: 
Course expires: 

Melinda M. Rathkopf, MD, FACAAI
Gary N. Gross, MD, FACAAI  
Kay Tyler, BS, BA, MBA
Robert Ellis, CPA  
Jennifer Kuehn, CPC
Thomas J Derrico, BBA
Priya J. Bansal, MD, FACAAI  
Shawn E. Hardee

Available Credit

  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Attendance
  • 5.00 CBRN


Please login or create an account to take this course.